It has been a while since we last wrote about Inghams shares (ASX:ING) - 8 months to be exact. It was in the immediate aftermath of the poultry company's FY24 results that investors loathed, sending them down 20% in a day. This was actually the second time Inghams shares crashed after releasing results, because a…
Its always reporting season in New Zealand in May as well as November, because many companies there follow an April 1-March 31 financial year.
While there are some exemptions that follow the calendar or Australian financial years (July to June), many Kiwi companies still use the Kiwi financial year. And they can do so as long…
Developing a cancer drug is a long journey, but Immutep (ASX:IMM) is more towards the end than the start. A few months ago, when it received its latest capital injection (of $100m), the company told its investors it was less than three years away from commercialising its cancer drug.
Immutep's share price may not suggest it…
Recce Pharmaceuticals (ASX:RCE, FSE:R9Q) is a Phase 3 ASX biotech that is close to unlocking its market opportunity. It is expecting to complete its Phase 3 trials during FY26 (the 12 months starting on July 1, 2025), and success here would lead to unlocking of market opportunities worth a cumulative US$9.1bn. Specifically, the global DFI…
Investors are wondering which will be the next ASX gold stocks to be acquired. There has been a flurry of M&A activity this year, the latest deal of which was confirmed to go ahead yesterday with Gold Roads being bought by Gold Fields for $3.9bn.
There have been other deals too including a merger between Westgold…
XPON Technologies (ASX:XPN) achieved something on Monday May 5 that few companies achieve - rising more than 200% in a single day. Shares peaked at 2.7c, >300% up from the 0.6c per share it closed Friday at before ultimately closing at 2.0c (up 233%). Even so, the ASX penny stock is only capped at $4.4m.
Why…
After many decades at the helm of Berkshire Hathaway, Warren Buffett is retiring. After founding his empire in 1965, he built it into a US$1tn+ empire owning many of America's best companies and profiting off them. But of course, all good things must come to an end - at least a tenure led by the…
Investors should always be on the look out for red flags for stocks. We're talking about subtle signs that may not appear to mean much in isolation, but could indicate that you have a bad company and you need to get out of it before you risk making a big loss on your investment.
Here 4…
Capricorn Metals (ASX:CMM) is one of several gold miners on the ASX that has slid under the radar of many investors, but delivered spectacular returns to those who took the gamble. In the last five years, it has gained over 600%, all thanks to one gold mine in WA.
The company is about to bring a…
ESG has become one of the most popular acronyms in the investing world, and a quickly growing trend. Few investors would put their hand up and say they want their investing to have a bad impact on the world around them.
There is evidence to suggest ESG funds perform better than funds without such a focus…
